In our study, the two affected boys showed typical PHA2 presentation, but their 32- and 28-year-old father and mother both had the same KLHL3 mutation, respectively, but were asymptomatic and had no hyperkalemia. This evidence concerns the gene KLHL3 and Hyperkalemia.